NCT03191318 (BARI-ERAS) is a NA clinical trial of ERAS pathway in Morbid Obesity, sponsored by GEM Hospital & Research Center.

Who is sponsoring NCT03191318?

NCT03191318 is sponsored by GEM Hospital & Research Center.

What drugs are being tested in NCT03191318?

Interventions in NCT03191318: ERAS pathway, Standard pathway.

What condition does NCT03191318 study?

NCT03191318 studies Morbid Obesity.

Is NCT03191318 still recruiting?

NCT03191318 is currently completed. Last updated 23 October 2018.

Last reviewed 2018-10-23 · How we verify

NCT03191318: BARI-ERAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Enhanced Recovery After Surgery (ERAS) Pathway With Conventional Pathway After Laparoscopic Sleeve Gastrectomy

Completed NA Last updated 23 October 2018

What this trial tests

NA trial testing ERAS pathway in Morbid Obesity in 60 participants. Completed in 1 August 2018.

Timeline

1 September 2017

Primary endpoint
1 July 2018

1 August 2018

Quick facts

Lead sponsor	GEM Hospital & Research Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 September 2017
Primary completion	1 July 2018
Estimated completion	1 August 2018
Sites	1 location across India

Drugs / interventions tested

ERAS pathway
Standard pathway

Conditions studied

Morbid Obesity — all drugs for Morbid Obesity →

Sponsor

GEM Hospital & Research Center

Who can join

Adults 18 to 65, any sex, with Morbid Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare two postoperative recovery pathways namely, enhanced recovery after surgery (ERAS) pathway and conventional recovery pathway after laparoscopic sleeve gastrectomy with respect to outcomes including hospital stay, postoperative pain and other postoperative outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Randomized Controlled Trial Comparing the Outcomes of Enhanced Recovery After Surgery and Standard Recovery Pathways in Laparoscopic Sleeve Gastrectomy.
Prabhakaran S, Misra S, Magila M, Kumar SS, et al · · 2020 · cited 18× · PMID 32291702 · DOI 10.1007/s11695-020-04585-2

Verify or expand the search:

Other trials of ERAS pathway

Trials testing the same drug.

NCT05931796 — Enhanced vs Conventional Recovery After Breast Surgery · NA · completed
NCT04306003 — ERAS in Autologous Breast Reconstruction: A Pilot RCT · NA · completed

Other recruiting trials for Morbid Obesity

Currently open trials in the same condition.

NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
NCT06413264 — Ultrasonography Guided Pneumoperitoneum for Laparoscopic Surgery in Morbidly Obese Patients · NA · recruiting
NCT07289555 — Tailored Stapled SADI-S: Initial Report and Preliminary Results · NA · recruiting
NCT07263269 — Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in · NA · active not recruiting
NCT06293703 — Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study) · NA · recruiting

Other GEM Hospital & Research Center trials

Trials by the same sponsor.

NCT04652336 — Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG · NA · unknown
NCT03727126 — Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer · NA · unknown
NCT03563092 — Closed Suction Drain vs no Drain on Symptomatic Seroma Formation After Laparoscopic Inguinal Hernia Repair · NA · completed
NCT03342040 — Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03191318 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GEM Hospital & Research Center
Last refreshed: 23 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03191318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing